Pomerantz LLP Investigates Enova Securities Fraud Claims After Bank Application Withdrawal

Pomerantz LLP is investigating securities fraud claims on behalf of investors of Enova International, Inc., the firm said in a November 10, 2026 alert published by FinancialContent Business Page. The investigation concerns whether Enova and certain of its officers or directors engaged in securities fraud or other unlawful business practices.

Pomerantz's Enova Investigation and the Grasshopper Withdrawal

Pomerantz LLP is a plaintiff-side securities litigation law firm founded in 1936 that represents investors in securities class actions, corporate governance cases and global investor recovery proceedings, according to company records. The firm advises Enova investors to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation follows Enova's September 14, 2026 announcement that it had withdrawn its Comptroller of the Currency and Federal Reserve applications for its proposed acquisition of Grasshopper Bancorp, a deal that would have made Enova a bank holding company. Enova said bank regulatory guidelines and attitudes "have not kept pace with the realities of" consumers, and that regulators lack clear standards for nonbanks seeking to become banks.

Enova also said the process is "susceptible to political pressure and outside advocacy, rather than being guided strictly by the statutory factors that should govern it." On the news, Enova's stock price fell $53.11 per share, or 23.43%, to close at $173.61 per share on September 15, 2026.

Pomerantz's Litigation Track Record

Pomerantz LLP maintains a global network of offices across New York, Chicago, Los Angeles, London, Paris and Tel Aviv, according to akta.pro company records. The firm's historic recovery for investors in the Petrobras securities litigation stands at $3 billion, and its recoveries include $350 million for United Healthcare investors and $225 million for Comverse Technology investors.

Earlier Pomerantz Investor Alerts

Pomerantz LLP announced a proposed class action settlement for purchasers of Gritstone bio securities on September 28, 2026, with a $6 million settlement fund and a hearing set for December 4, 2026, PR Newswire reported. On September 1, 2026, the firm announced a class action lawsuit against Taboola.com Ltd. over alleged securities fraud, FinancialContent Business Page reported. Pomerantz announced on August 25, 2026 that a class action had been filed against GPGI, Inc. alleging securities fraud or unlawful business practices, FinancialContent Business Page reported.

Enova's $500 Million Buyback

Enova's board authorized a $500 million share repurchase program expiring June 30, 2028, replacing a $400 million program that would have expired in June 2027, Stock Titan reported on November 10, 2026. The company called it the largest in its history, citing strong balance sheet and liquidity.